Autologous hematopoietic stem cell transplantation for efficient treatment of multisystem, high-risk, BRAF V600E-negative Langerhans cell histiocytosis:

Yaozhu Pan,Rui Xi,Cun-Bang Wang,Lei Fang,Jiaofeng Bai,Yonggang Cai,Min Guo,Rui-Yun Qiao,Xu Lan,Jiao-jiao Yin,Ke Yang,Hai Bai

Autologous hematopoietic stem cell transplantation for efficient treatment of multisystem, high-risk, BRAF V600E-negative Langerhans cell histiocytosis:

2019

Yaozhu Pan
Rui Xi
Cun-Bang Wang
Lei Fang
Jiaofeng Bai
Yonggang Cai
Min Guo
Rui-Yun Qiao
Xu Lan
Jiao-jiao Yin
Ke Yang
Hai Bai

Langerhans cell histiocytosis (LCH) is a disorder caused by clonal proliferation of CD1a+/CD207+ cells and characterized by varying degrees of organ involvement. Treatment of LCH is risk adapted; p...

Keywords:

Medicine
Langerhans cell histiocytosis
BRAF V600E
Diabetes mellitus
Hematopoietic stem cell transplantation
Anesthesia
Cancer research
organ involvement
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations